| Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ... The Lancet Oncology 19 (4), 521-536, 2018 | 542 | 2018 |
| Tumour class prediction and discovery by microarray-based DNA methylation analysis P Adorján, J Distler, E Lipscher, F Model, J Müller, C Pelet, A Braun, ... Nucleic acids research 30 (5), e21-e21, 2002 | 400 | 2002 |
| Slit-lamp-adapted optical coherence tomography of the anterior segment H Hoerauf, C Wirbelauer, C Scholz, R Engelhardt, P Koch, H Laqua, ... Graefe's archive for clinical and experimental ophthalmology 238, 8-18, 2000 | 250 | 2000 |
| Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation C Scholz, KT Patton, DE Anderson, GJ Freeman, DA Hafler The Journal of Immunology 160 (3), 1532-1538, 1998 | 250 | 1998 |
| Transscleral optical coherence tomography: a new imaging method for the anterior segment of the eye H Hoerauf, C Scholz, P Koch, R Engelhardt, H Laqua, R Birngruber Archives of Ophthalmology 120 (6), 816-819, 2002 | 211 | 2002 |
| The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited … SE Al-Batran, TO Goetze, DW Mueller, A Vogel, M Winkler, S Lorenzen, ... BMC cancer 17, 1-7, 2017 | 170 | 2017 |
| Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study PC Thuss-Patience, A Kretzschmar, M Repp, D Kingreen, D Hennesser, ... Journal of Clinical Oncology 23 (3), 494-501, 2005 | 164 | 2005 |
| Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive … A Korfel, T Elter, E Thiel, M Hänel, R Möhle, R Schroers, M Reiser, ... haematologica 98 (3), 364, 2013 | 147 | 2013 |
| Noncontact corneal pachymetry with slit lamp-adapted optical coherence tomography C Wirbelauer, C Scholz, H Hoerauf, DT Pham, H Laqua, R Birngruber American journal of ophthalmology 133 (4), 444-450, 2002 | 141 | 2002 |
| Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro H Liu, C Scholz, C Zang, JH Schefe, P Habbel, AC Regierer, CO Schulz, ... Anticancer research 32 (5), 1627-1637, 2012 | 136 | 2012 |
| 90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical … CW Scholz, A Pinto, W Linkesch, O Lindén, A Viardot, U Keller, G Hess, ... Journal of clinical oncology 31 (3), 308-313, 2013 | 129 | 2013 |
| Costimulation by CD137/4–1BB inhibits T cell apoptosis and induces Bcl‐xL and c‐FLIPshort via phosphatidylinositol 3‐kinase and AKT/protein kinase B L Stärck, C Scholz, B Dörken, PT Daniel European journal of immunology 35 (4), 1257-1266, 2005 | 121 | 2005 |
| Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway C Scholz, T Wieder, L Stärck, F Essmann, K Schulze-Osthoff, B Dörken, ... Oncogene 24 (11), 1904-1913, 2005 | 110 | 2005 |
| Corneal optical coherence tomography before and immediately after excimer laser photorefractive keratectomy C Wirbelauer, C Scholz, H Hoerauf, R Engelhardt, R Birngruber, H Laqua American journal of ophthalmology 130 (6), 693-699, 2000 | 93 | 2000 |
| First experimental and clinical results with transscleral optical coherence tomography H Hoerauf, RS Gordes, C Scholz, C Wirbelauer, P Koch, R Engelhardt, ... Ophthalmic Surgery, Lasers and Imaging Retina 31 (3), 218-222, 2000 | 78 | 2000 |
| Process and arrangement for examining a section of the eye R Birngruber, C Scholz, P Koch, R Engelhardt US Patent 6,095,648, 2000 | 76 | 2000 |
| Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory … M Thomas, S Ponce-Aix, A Navarro, J Riera-Knorrenschild, M Schmidt, ... Annals of Oncology 29 (10), 2076-2084, 2018 | 68 | 2018 |
| Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. P Höllsberg, C Scholz, DE Anderson, EA Greenfield, VK Kuchroo, ... Journal of immunology (Baltimore, Md.: 1950) 159 (10), 4799-4805, 1997 | 67 | 1997 |
| Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down‐regulation of Mcl‐1 in mantle cell lymphoma A Müller, C Zang, C Chumduri, B Dörken, PT Daniel, CW Scholz International Journal of Cancer 133 (8), 1813-1824, 2013 | 64 | 2013 |
| Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway C Scholz, A Richter, M Lehmann, K Schulze-Osthoff, B Dörken, PT Daniel Oncogene 24 (47), 7031-7042, 2005 | 62 | 2005 |
